Skip to main content
XXII
NASDAQ Manufacturing

Q3 Revenue Jumps 66% Sequentially to $4.8M as Gross Profit Turns Positive

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Industrial
Sentiment info
Negative
Importance info
7
Price
$0.71
Mkt Cap
$424.216K
52W Low
$0.721
52W High
$20,314.465
52W Position info
1.6% below low
Off High info
100% below high
Rel. Volume info
36× avg
Market data snapshot near publication time

XXII is trading near its 52-week low of $0.721 (1.6% below the low) on elevated volume (36× avg).

Summary

Revenue rose 66% sequentially to $4.8 million from $2.9 million in Q2, and gross profit flipped to $0.4 million from a $(0.3) million loss. Versus the year-ago quarter, revenue was up 18.6% to $4.759 million while the operating loss narrowed to $2.6 million from $3.2 million and the adjusted EBITDA loss improved to $2.2 million from $2.9 million. The growth is coming from higher-margin cigarette sales ($3.9 million, up from $2.3 million) as the company shifts away from low-priced CMO export customers; VLN cigarette revenue was still just $0.03 million. Management also flagged a 166% sequential increase in point-of-sale pack sales at its retail launch partner, a GoPuff distribution deal, approvals in 13 more states and shipments into roughly 150 new stores in metro New York and northern New Jersey. Post-quarter they raised $5.8 million net through the ATM, used $1.2 million to redeem Series B preferred at par, and now have no warrants outstanding — a cleaner cap table after the 1-for-58 reverse split effective November 5. Cash stood at $3.9 million on September 30, so the ATM remains the funding lifeline; the 8:00 a.m. ET call is the next checkpoint on margin durability and VLN sell-through. The quarter's loss per share was $247.80.

At the time of this announcement, XXII was trading at $0.71 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $424.2K. The 52-week trading range was $0.72 to $20,314.46. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

XXII - Latest Insights

XXII
Nov 16, 2026, 6:31 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.7208
Real-time Price: $0.5177 info
Change: -$0.2031 (-28%) info
Market Cap: $280.277K info
XXII
Nov 16, 2026, 6:02 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.690
Real-time Price: $0.5177 info
Change: -$0.1723 (-25%) info
Market Cap: $280.277K info
XXII
Nov 03, 2026, 12:35 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.0565
Real-time Price: $0.5177 info
Change: Reverse Stock Split info
Market Cap: $280.277K info
XXII
Nov 03, 2026, 11:40 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.06355
Real-time Price: $0.5177 info
Change: Reverse Stock Split info
Market Cap: $280.277K info
XXII
Oct 23, 2026, 6:22 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.1359
Real-time Price: $0.5177 info
Change: Reverse Stock Split info
Market Cap: $280.277K info